EVERYTHING ABOUT HEMGENIX

Amount of qualified clients: CDEC talked over the uncertainty in the number of patients with reasonably severe to severe hemophilia B in Canada suitable for etranacogene dezaparvovec. Scientific gurus consulted by CADTH indicated that some clients that are labeled as possessing gentle or moderate illness may have a intense bleeding phenotype, which